Cover Image
市場調查報告書

分子診斷市場(PCR、新一代定序、微陣列、感染疾病、遺傳病、腫瘤學檢驗、血液捐贈者篩檢):全球產業分析、規模、市場佔有率、成長、趨勢及預測

Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 294642
出版日期 內容資訊 英文 122 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷市場(PCR、新一代定序、微陣列、感染疾病、遺傳病、腫瘤學檢驗、血液捐贈者篩檢):全球產業分析、規模、市場佔有率、成長、趨勢及預測 Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年02月06日 內容資訊: 英文 122 Pages
簡介

分子診斷雖然至今都需要高技術專家與高價實驗,但成本削減及客製化的改良、先進技術的引進下,而廣泛利用於分子診斷檢查上。由於院內感染發病率的上升、高齡化、患者意識的提升等要素,一般預測該市場在今後將會持續普及。

本報告提供全球分子診斷市場相關調查,彙整各種技術和應用趨勢,市場規模與未來預測,各地區趨勢,競爭環境等資料,連同企業簡介,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場趨勢

  • 概要
  • 推動市場的要素
    • 癌症發病數量的增加
    • 高齡化
    • 慢性疾病發病率的上升
    • 搭配診斷及個人化醫療的認識和普及度擴大
  • 阻礙要素
    • 給付政策相關問題
  • 市場機會
    • 技術進步
    • 新興市場開拓
  • 波特五力分析模式
  • 市場魅力度分析:各地區

第4章 分子診斷市場:各技術

  • 概要
  • 聚合酵素鏈鎖反應(PCR)
  • 轉錄擴增(TMA)
  • 微陣列
  • 混合化(ISH及FISH)
  • 新一代定序
  • 其他

第5章 分子診斷市場:各技術:各方面應用

  • 概要
  • 感染疾病
  • 基因學
  • 血液捐贈者篩檢
  • 其他

第6章 分子診斷市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第7章 分子診斷市場佔有率分析

  • 全球分子診斷市場各主要企業市場佔有率分析

第8章 建議

  • 成功策略
    • 跟醫療保健服務供應商的長期契約
    • 中國,印度,俄羅斯等新興國家的投資
    • 流通網的擴大

第9章 企業簡介

  • Abbott Laboratories
  • Becton Dickinson & Company
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Danaher Corporation (Beckman Coulter)
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc. (Gen-Probe)
  • Myriad Genetics, Inc.
  • Novartis International AG
  • Qiagen
  • Quest Diagnostics, Inc.
  • Siemens AG
  • Thermo Fisher Scientific

圖表

目錄

Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.

The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders, oncology, HLA testing and pharmacogenetics testing. The infectious diseases segment comprises market for HIV infections, HAI, HCV infections and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.

The market has also been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global molecular diagnostics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter's five forces analysis for the molecular diagnostics market.

Market players are profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others.

The global molecular diagnosticsmarket is segmented into the following categories:

Molecular DiagnosticsMarket, by Technology

  • PCR
  • Transcription mediated amplification (TMA)
  • Next generation sequencing
  • Microarray
  • Hybridization techniques
  • Others

Molecular DiagnosticsMarket, by Application

  • Infectious diseases
    • Virology
    • HIV testing
    • HPV testing
    • HCV testing
    • Others
    • Bacteriology
    • HAI testing
    • CT/NG testing
    • Others
  • Genomics
    • Genetic testing for inherited disorders
    • Human Leukocyte Antigen (HLA) testing
    • Pharmacogenetics testing
    • Oncology Testing
  • Blood Donor Screening
  • Others

Molecular DiagnosticsMarket, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
  • 2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Rising incidence of cancer cases
    • 3.2.2 Aging population
    • 3.2.3 Increase in incidence of chronic diseases
    • 3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines
  • 3.3 Market Restraints
    • 3.3.1 Issues with reimbursement policies
  • 3.4 Market Opportunities
    • 3.4.1 Technological advancements
    • 3.4.2 Tapping the emerging economies
  • 3.5 Porter's Five Force Analysis: Global Molecular Diagnostics Market
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of New Entrants
    • 3.5.4 Threat of Substitutes
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography

Chapter 4 Molecular Diagnostics Market, by Technology

  • 4.1 Overview
    • 4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • 4.2 Polymerase Chain Reaction (PCR)
    • 4.2.1 Global PCR Market, 2011 - 2019 (USD Million)
  • 4.3 Transcription Mediated Amplification (TMA)
    • 4.3.1 Global TMA Market, 2011 - 2019 (USD Million)
  • 4.4 Microarray
    • 4.4.1 Global Microarray Market, 2011 - 2019 (USD Million)
  • 4.5 Hybridization (ISH and FISH)
    • 4.5.1 Global Hybridization Market, 2011 - 2019 (USD Million)
  • 4.6 Next-generation sequencing
    • 4.6.1 Global Next generation sequencing Market, 2011 - 2019 (USD Million)
  • 4.7 Others
    • 4.7.1 Global Others Market, 2011 - 2019 (USD Million)

Chapter 5 Global Molecular Diagnostics Market, by Applications

  • 5.1 Overview
    • 5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 - 2019 (USD Million)
  • 5.2 Infectious Diseases
    • 5.2.1 Global Infectious Diseases Market, by Segments, 2011 - 2019 (USD Million)
    • 5.2.2 Virology
      • 5.2.2.1 Global Virology Market, by Segments, 2011 - 2019 (USD Million)
      • 5.2.2.2 Human immunodeficiency virus (HIV) testing
        • 5.2.2.2.1 Global HIV testing Market, 2011 - 2019 (USD Million)
      • 5.2.2.3 Human papillomavirus (HPV) testing
        • 5.2.2.3.1 Global HPV testing Market, 2011 - 2019 (USD Million)
      • 5.2.2.4 Hepatitis C virus (HCV) testing
        • 5.2.2.4.1 Global HCV testing Market, 2011 - 2019 (USD Million)
      • 5.2.2.5 Others
        • 5.2.2.5.1 Global Others testing Market, 2011 - 2019 (USD Million)
    • 5.2.3 Bacteriology
      • 5.2.3.1 Global Bacteriology Market, by Segments, 2011 - 2019 (USD Million)
      • 5.2.3.2 Hospital Acquired Infection (HAI) testing
        • 5.2.3.2.1 Global HAI testing Market, 2011 - 2019 (USD Million)
      • 5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing
        • 5.2.3.3.1 Global CT/NG testing Market, 2011 - 2019 (USD Million)
      • 5.2.3.4 Others
        • 5.2.3.4.1 Global Others testing Market, 2011 - 2019 (USD Million)
  • 5.3 Genomics
    • 5.3.1 Global Genomics Market, by Segments, 2011 - 2019 (USD Million)
    • 5.3.2 Genetic testing for inherited disorders
      • 5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 - 2019 (USD Million)
    • 5.3.3 Human Leukocyte Antigen (HLA)testing
      • 5.3.3.1 Global HLA testing Market, 2011 - 2019 (USD Million)
    • 5.3.4 Pharmacogenetics testing
      • 5.3.4.1 Global Pharmacogenetics testing Market, 2011 - 2019 (USD Million)
    • 5.3.5 Oncology testing
      • 5.3.5.1 Global Oncology testing Market, 2011 - 2019 (USD Million)
  • 5.4 Blood Donor Screening
    • 5.4.1 Global Blood donor screening testing Market, 2011 - 2019 (USD Million)
  • 5.5 Others
    • 5.5.1 Global Others testing Market, 2011 - 2019 (USD Million)

Chapter 6 Global Molecular Diagnostics Market, by Geography

  • 6.1 Overview
    • 6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 - 2019 (USD Million)
  • 6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
  • 6.3 North America
    • 6.3.1 North America Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
    • 6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
    • 6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • 6.5 Asia-Pacific
    • 6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
    • 6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • 6.6 RoW
    • 6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
    • 6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)

Chapter 7 Global Molecular Diagnostics Market Share Analysis

  • 7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market
    • 7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%)
    • 7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market

Chapter 8 Recommendations

  • 8.1 Market Strategies for Success
    • 8.1.1 Long term contracts with healthcare service providers
    • 8.1.2 Investing in emerging economies such as China, India and Russia
    • 8.1.3 Broadening of distribution network

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
    • 9.1.1 Company Overview
    • 9.1.2 Financial Overview
    • 9.1.3 Product Portfolio
    • 9.1.4 Business Strategies
    • 9.1.5 Recent Developments
  • 9.2 Becton Dickinson & Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Overview
    • 9.2.3 Product Portfolio
    • 9.2.4 Business Strategies
    • 9.2.5 Recent Developments
  • 9.3 bioMerieux
    • 9.3.1 Company Overview
    • 9.3.2 Financial Overview
    • 9.3.3 Product Portfolio
    • 9.3.4 Business Strategies
    • 9.3.5 Recent Developments
  • 9.4 Bio-Rad
    • 9.4.1 Company Overview
    • 9.4.2 Financial Overview
    • 9.4.3 Product Portfolio
    • 9.4.4 Business Strategies
    • 9.4.5 Recent Developments
  • 9.5 Cepheid
    • 9.5.1 Company Overview
    • 9.5.2 Financial Overview
    • 9.5.3 Product Portfolio
    • 9.5.4 Business Strategies
    • 9.5.5 Recent Developments
  • 9.6 Danaher Corporation (Beckman Coulter)
    • 9.6.1 Company Overview
    • 9.6.2 Financial Overview
    • 9.6.3 Product Portfolio
    • 9.6.4 Business Strategies
    • 9.6.5 Recent Developments
  • 9.7 F. Hoffmann-La Roche Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Overview
    • 9.7.3 Product Portfolio
    • 9.7.4 Business Strategies
    • 9.7.5 Recent Developments
  • 9.8 Hologic, Inc. (Gen-Probe)
    • 9.8.1 Company Overview
    • 9.8.2 Financial Overview
    • 9.8.3 Product Portfolio
    • 9.8.4 Business Strategies
    • 9.8.5 Recent Developments
  • 9.9 Myriad Genetics, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Portfolio
    • 9.9.4 Business Strategies
    • 9.9.5 Recent Developments
  • 9.10 Novartis International AG
    • 9.10.1 Company Overview
    • 9.10.2 Financial Overview
    • 9.10.3 Product Portfolio
    • 9.10.4 Business Strategies
  • 9.11 Qiagen
    • 9.11.1 Company Overview
    • 9.11.2 Financial Overview
    • 9.11.3 Product Portfolio
    • 9.11.4 Business Strategies
    • 9.11.5 Recent Developments
  • 9.12 Quest Diagnostics, Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Financial Overview
    • 9.12.3 Product Portfolio
    • 9.12.4 Business Strategies
    • 9.12.5 Recent Developments
  • 9.13 Siemens AG
    • 9.13.1 Company Overview
    • 9.13.2 Financial Overview
    • 9.13.3 Product Portfolio
    • 9.13.4 Business Strategies
    • 9.13.5 Recent Developments
  • 9.14 Thermo Fisher Scientific
    • 9.14.1 Company Overview
    • 9.14.2 Financial Overview
    • 9.14.3 Product Portfolio
    • 9.14.4 Business Strategies
    • 9.14.5 Recent Developments

List of Figures

  • FIG. 1 Molecular Diagnostics: Market Segmentation
  • FIG. 2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
  • FIG. 1 Porter's Five Force Analysis: Global Molecular Diagnostics Market
  • FIG. 2 Market Attractiveness Analysis : Global Molecular Diagnostics Market, by Geography
  • FIG. 3 Global PCR Market, 2011 - 2019 (USD Million)
  • FIG. 4 Global TMA Market, 2011 - 2019 (USD Million)
  • FIG. 5 Global Microarray Market, 2011 - 2019 (USD Million)
  • FIG. 6 Global Hybridization Market, 2011 - 2019 (USD Million)
  • FIG. 7 Global Next generation sequencing Market, 2011 - 2019 (USD Million)
  • FIG. 8 Global Others Market, 2011 - 2019 (USD Million)
  • FIG. 9 Global HIV testing Market, 2011 - 2019 (USD Million)
  • FIG. 10 Global HPV testing Market, 2011 - 2019 (USD Million)
  • FIG. 11 Global HCV testing Market, 2011 - 2019 (USD Million)
  • FIG. 12 Global Others testing Market, 2011 - 2019 (USD Million)
  • FIG. 13 Global HAI testing Market, 2011 - 2019 (USD Million)
  • FIG. 14 Global CT/NG testing Market, 2011 - 2019 (USD Million)
  • FIG. 15 Global Others testing Market, 2011 - 2019 (USD Million)
  • FIG. 16 Global Genetic testing for inherited disorders Market, 2011 - 2019 (USD Million)
  • FIG. 17 Global HLA testing Market, 2011 - 2019 (USD Million)
  • FIG. 18 Global Pharmacogenetics testing Market, 2011 - 2019 (USD Million)
  • FIG. 19 Global Oncology testing Market, 2011 - 2019 (USD Million)
  • FIG. 20 Global Blood donor screening testing Market, 2011 - 2019 (USD Million)
  • FIG. 21 Global Others testing Market, 2011 - 2019 (USD Million)
  • FIG. 22 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 23 Global Molecular Diagnostics: Market Share, by Key Players, 2012 (%)
  • FIG. 24 Abbott Laboratories, Inc., Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 25 Becton Dickinson: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 26 bioMerieux: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 27 Bio-Rad: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 28 Cepheid: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 29 Danaher Corporation: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 30 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 31 Hologic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 32 Myriad Genetics, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 33 Novartis International AG.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 34 Qiagen N.V.,: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 35 Quest Diagnostics: Annual Revenue,2010 - 2012 (USD Million)
  • FIG. 36 Siemens AG : Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 37 Thermo Fisher Scientific: Annual Revenue,2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
  • TABLE 2 Global Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 3 Global Molecular Diagnostics Market, by Applications, 2011 - 2019 (USD Million)
  • TABLE 4 Global Infectious Diseases Market, by Segments, 2011 - 2019 (USD Million)
  • TABLE 5 Global Virology Market, by Segments, 2011 - 2019 (USD Million)
  • TABLE 6 Global Bacteriology Market, by Segments, 2011 - 2019 (USD Million)
  • TABLE 7 Global Genomics Market, by Segments, 2011 - 2019 (USD Million)
  • TABLE 8 Global Molecular Diagnostics Market, by Geography, 2011 - 2019 (USD Million)
  • TABLE 9 North America Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
  • TABLE 10 North America Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 11 Europe Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
  • TABLE 12 Europe Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 13 Asia Pacific Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
  • TABLE 14 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 15 RoW Molecular Diagnostics Market, by Application, 2011 - 2019 (USD Million)
  • TABLE 16 RoW Molecular Diagnostics Market, by Technology, 2011 - 2019 (USD Million)
  • TABLE 17 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market (2012)
Back to Top